✉news HealthMedicine first seen 3 d ago, last 3 d ago, peak #18
AI companies run virtual drug trials to boost human study success
Original: Focus: AI companies run virtual drug trials, aim to improve success of human studies
Artificial intelligence companies are running simulated, or virtual, drug trials before launching real human studies, aiming to identify promising compounds and reduce the high failure rate of clinical trials. The approach, reported by Reuters, could cut costs and speed up drug development, though questions remain about how reliably computer models can predict outcomes in actual patients.
Why now: Growing interest in whether AI simulations can make clinical trials cheaper and more successful.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1402135